Druggable Nucleolin Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes

Meeting the needs of breast cancer: A nucleolin’s perspective

(2018) Ana C. Gregório et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Integrated analysis of mRNA and miRNA expression in HeLa cells expressing low levels of Nucleolin

(2017) Sanjeev Kumar et al.   Scientific Reports

Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients

(2017) Virginie Marcel et al.   PLoS One

Research needs in breast cancer

(2016) F. Cardoso et al.   ANNALS OF ONCOLOGY

Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature

(2016) Maud-Emmanuelle Gilles et al.   CANCER RESEARCH

Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer

(2016) Eya Wolfson et al.   Oncotarget

The roles of nucleolin subcellular localization in cancer

(2015) Caroline Madeleine Berger et al.   BIOCHIMIE

Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

(2015) Giovanni Ciriello et al.   CELL

Centrosomal nucleolin is required for microtubule network organization

(2015) Xavier Gaume et al.   CELL CYCLE

Human anti-nucleolin recombinant immunoagent for cancer therapy

(2015) Dario Palmieri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Increased level of nucleolin confers to aggressive tumor progression and poor prognosis in patients with hepatocellular carcinoma after hepatectomy

(2014) XiaoDong Guo et al.   Diagnostic Pathology

Overexpression of nucleolin and different expression sites both related to the prognosis of gastric cancer

(2013) Wensheng Qiu et al.   APMIS

A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma

(2013) Jonathan E. Rosenberg et al.   INVESTIGATIONAL NEW DRUGS

In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

(2013) Flavia Pichiorri et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Prognostic Significance of the Combined Score of Endothelial Expression of Nucleolin and CD31 in Surgically Resected Non-Small Cell Lung Cancer

(2013) Hongyun Zhao et al.   PLoS One

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer

(2013) Virginie Maire et al.   PLoS One

High Levels of Nucleolar Expression of Nucleolin Are Associated with Better Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

(2010) L. Peng et al.   CLINICAL CANCER RESEARCH

Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization

(2010) Ara G. Hovanessian et al.   PLoS One

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma

(2008) Lee Ridley et al.   NEURO-ONCOLOGY

Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin

(2008) Damien Destouches et al.   PLoS One